ITLN1 and inflammatory bowel disease: In addition, we observed that patients with IBD also exhibited lower serum levels of omentin (295.2 ± 76.1 vs. 367.7 ± 132.0 ng/mL in patients with and without IBD, respectively, p = 0.019) (Fig. 2c).